Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021
14. März 2022 08:00 ET
|
Abcam
Growing demand for Abcam’s portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision completed 26 October 2021 CAMBRIDGE, United...
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
13. September 2021 07:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research...
Abcam to Acquire BioVision for $340 million
02. August 2021 02:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research...
Abcam and MEDx extend precision medicine strategic partnership
12. April 2021 05:00 ET
|
Abcam
Building on existing three-year collaborationFocusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12,...
Abcam Wins Industry Awards from CiteAb
24. März 2021 07:49 ET
|
Abcam
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of...
8.3% constant currency revenue growth in H1 as customers gradually return to labs
08. März 2021 07:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group” or the “Company”), a global leader in the supply of life science research...
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
04. März 2021 04:00 ET
|
Abcam
Scaling up R&D, manufacturing and commercial capabilities in Shanghai and Hangzhou Investing in state-of-the-art facilities and equipment to support research, diagnostic and clinical applications ...
Abcam to Report Interim Results on Monday, March 8, 2021
26. Februar 2021 02:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report...
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference
17. Februar 2021 07:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global...
Abcam Plc Appointment of Non-Executive Directors
28. Januar 2021 02:00 ET
|
Abcam
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the...